The two programs are being conducted under separate Single-Patient Investigational New Drug (sIND) applications in the United ...
The anti-abortion movement’s patience with the Food and Drug Administration (FDA) is wearing thin following the agency’s ...
The US Food and Drug Administration will review evidence about the safety and efficacy of mifepristone, one of the drugs used ...
The vaccine advisory committee is scheduled to meet next week to review and make recommendations for this fall’s updated ...
An FDA review of mifepristone is sparking concern over politics outweighing science, even as the agency approved a new ...
The FDA approved the updated COVID-19 vaccinations for all seniors, but limited access for younger adults and children. Pfizer's vaccine won't be available for children under 5 after the FDA pulled ...
The drug will now be produced by Evita Solutions LLC, which describes its mission as being to ‘normalize abortion’ ...
Attorney General Nick Brown, along with 19 other attorneys general, has issued a joint statement affirming the safety and accessibility of the medical abortion ...
Medical journals and National Comprehensive Cancer Network guidelines rarely publish FDA-identified uncertainties about new ...
The U.S. Food and Drug Administration is changing its policy on who should get COVID-19 shots, potentially limiting access to new vaccine formulations as they enter the market. New and updated jabs ...
The FDA recently launched a new Adverse Event Reporting System exclusively for cosmetic products, part of a larger effort to promote greater transparency for consumers, the agency announced in a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback